Co-founder and CEO of Biotia, Research Assistant Professor at SUNY Downstate Health Sciences University
BIOGRAPHY
Precision infectious disease discovery using next-generation sequencing and AI to provide insights into respiratory, urine, and stool samples
Presented at:
Microbiology Week Virtual Event Series 2020
Speaker
Abstract
Lessons around leveraging high-complexity next-generation sequencing tests for precision infectious disease discovery to guide patient treatment and improve health outcomes.
Learning Objectives:
1. Reviewing current available technology and limitations for microbial profiling
2. What is NGS and metagenomics
3. Applications of NGS in urine, stool, and respiratory samples and case studies
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Speaker:
Claudia Chiocchini
Presented at: Cancer Research & Oncology Virtual Event Series 2024
Sponsored By: Thermo Fisher Scientific
Sponsored By: Thermo Fisher Scientific
Loading Comments...
Please update your information
Certificate of Attendance
Thank you for choosing Labroots. Please note that a Certificate of Attendance does NOT count towards Continuing Education Credits.
DOWNLOAD CERTIFICATE
DOWNLOAD CERTIFICATE
You must watch the entire webinar to receive your certificate of attendance.
You must attend the event before receiving your certificate of attendance.
You must register for the event first.
Certificate is no longer available for this event.
You must be logged in to retrieve your certificate.